FAAH inhibitor URB597 shows anti-hyperalgesic action and increases brain and intestinal tissues fatty acid amides in a model of CRF1 agonist mediated visceral hypersensitivity in male rats

By sjmartinez • October 1, 2024

Larauche M, Mulak A, Ha C, Million M, Arnett S, Germano P, Pearson JP, Currie MG, Taché Y. FAAH inhibitor URB597 shows anti-hyperalgesic action and increases brain and intestinal tissues fatty acid amides in a model of CRF₁ agonist mediated visceral hypersensitivity in male rats. Neurogastroenterol Motil. 2024 Sep 30:e14927. doi: 10.1111/nmo.14927. Epub ahead of print. PMID: 39344695.

Tags: anandamide, cortagine, defecation, Digestive Diseases, Irritable Bowel Syndrome, Publications, rat, URB597, Veterans Administration, Visceral pain

Efficacy and Safety of Ustekinumab and Vedolizumab for Crohn’s Disease of the Pouch

Park S, Keyashian K, Ho A, Limsui D, Frost S, Vazquez R, Yang E, Ebriani J, Maas L, Parian A, Lazarev M, Parekh N, Sauk[...]

Association for Bariatric Endoscopy systematic review and meta-analysis assessing the American Society for Gastrointestinal Endoscopy preservation and incorporation of valuable endoscopic innovations thresholds for transoral outlet reduction

Jirapinyo P, Kumar N, Thompson CC, Law RJ, Muthusamy VR, Schulman AR, Sullivan S. Association for Bariatric Endoscopy systematic review and meta-analysis assessing the American[...]

ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease

Farraye FA, Melmed GY, Lichtenstein GR, Barnes EL, Limketkai BN, Caldera F, Kane S. ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease. Am[...]